ArticleCancers2021

Pharmacological or TRIB3-Mediated Suppression of ATF4 Transcriptional Activity Promotes Hepatoma Cell Resistance to Proteasome Inhibitor Bortezomib.

Tiit Örd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.